Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

INITIAL

threatened miscarriage

Back
1st line – 

analgesics plus counseling

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Pregnancies that continue require closer follow-up and targeted fetal surveillance. Many women who experience spontaneous vaginal bleeding in the first half of pregnancy have uneventful pregnancies thereafter.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
ACUTE

inevitable/incomplete/missed miscarriage

Back
1st line – 

manual evacuation

Remove the early pregnancy tissue digitally or with a sterile ovum or sponge-holding forceps.

Back
Plus – 

analgesics plus counseling

Treatment recommended for ALL patients in selected patient group

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples psychologically as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

misoprostol

Treatment recommended for SOME patients in selected patient group

Patients with severe vaginal bleeding or those who continue to bleed after a manual evacuation should receive misoprostol, a prostaglandin analog, even if early pregnancy tissue is removed from the upper vagina or cervical canal. This will aid complete emptying of the uterine cavity.[96]

Primary options

misoprostol: 800 micrograms intravaginally as a single dose, repeat once on day 3 if expulsion incomplete

More
Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
Back
1st line – 

conservative management

A significant number of women prefer conservative (or expectant) management allowing early pregnancy tissue to be expelled spontaneously. It may be continued as long as the patient is willing and provided there are no signs of infection such as vaginal discharge, heavy bleeding, pyrexia, or lower abdominal pain.

Follow-up scans may be arranged at 2-weekly intervals, until a diagnosis of complete miscarriage is made.

Ultrasound is preferred for confirming early pregnancy loss. The American College of Obstetricians and Gynecologists recommends that surgical intervention is not required in asymptomatic women who have a thickened endometrial stripe after undergoing treatment for pregnancy loss.[95]

Back
Plus – 

analgesics plus counseling

Treatment recommended for ALL patients in selected patient group

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
Back
2nd line – 

medical evacuation with misoprostol

Drugs used to facilitate or to effect uterine evacuation may have a role where vaginal bleeding is reasonably mild.[110][111][112]

The main drug therapy for nonsurgical management of miscarriage is misoprostol, a prostaglandin analog. The patient, however, needs to be informed that the surgical option may still be necessary if bleeding gets heavier or is persistent beyond a reasonable time. Vaginal bleeding after misoprostol therapy seems to be more prolonged and heavier, but seldom requires blood transfusion compared with after surgical evacuation.[105]

Primary options

misoprostol: 800 micrograms intravaginally as a single dose, repeat once on day 3 if expulsion incomplete

More
Back
Plus – 

analgesics plus counseling

Treatment recommended for ALL patients in selected patient group

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
Back
1st line – 

suction evacuation of the uterus ± antibiotics

A flexible or rigid plastic cannula is connected to a controlled suction outlet. It is important to ascertain the axis of the uterus before inserting the cannula.

Because suction evacuation of the uterus is undertaken with some form of regional or parenteral/general anesthetic, the risks of perforation are high. The most critical safeguards to this are to ascertain the cervico-uterine axis and to assess the approximate cervico-uterine cavity length.

The use of routine antibiotic prophylaxis in women with incomplete miscarriage and no signs of infection is controversial.[114]

Women with incomplete miscarriage who have one or more features: a foul-smelling vaginal discharge, fever, chills, lower abdominal pain, or feeling ill, may benefit from a preoperative course of antibiotics to be administered at least 1 hour before uterine evacuation.[115] Oral antibiotics may be prescribed for at least 3 days after surgery. In one study, administration of intravenous antibiotics preoperatively showed that oral antibiotics may not be necessary after 48 hours of clinical improvement.[116]

Antibiotics should be prescribed according to local guidelines.

Primary options

at increased risk of Chlamydia infection

doxycycline: 200 mg orally one hour preoperatively, followed by 100 mg orally twice daily for 10 days after surgery

OR

at increased risk of Chlamydia infection

azithromycin: 1 g orally as a single dose one hour preoperatively

OR

not at increased risk of Chlamydia infection

ampicillin/sulbactam: 3 g intravenously at least one hour preoperatively, followed by 1.5 g intravenously every 6 hours for 24 hours after surgery; a further 3-5 day course of oral antibiotics may be required

More

OR

not at increased risk of Chlamydia infection

clindamycin: 900 mg intravenously every 8 hours for 3 days starting one hour preoperatively

More

and

gentamicin: 2 mg/kg intravenously every 8 hours for 3 days starting one hour preoperatively

Back
Plus – 

analgesics plus counseling

Treatment recommended for ALL patients in selected patient group

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice. Compared with women who underwent medical evacuation with misoprostol, women who underwent manual vacuum aspiration had higher pain scores, although they had fewer side effects.[128]

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

oxytocics

Treatment recommended for SOME patients in selected patient group

May be used to facilitate or to effect uterine evacuation in patients undergoing surgical evacuation and to reduce postprocedure bleeding.

Primary options

oxytocin: consult specialist for guidance on dose

OR

misoprostol: consult specialist for guidance on dose

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

Women who are rhesus negative and unsensitized should receive Rho (D) immune globulin immediately after surgical management of miscarriage.[68][95]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
Back
1st line – 

medical evacuation with misoprostol

Drugs used to facilitate or to effect uterine evacuation may have a role where vaginal bleeding is reasonably mild.[110][111][112]

The main drug therapy for nonsurgical management of miscarriage is misoprostol, a prostaglandin analog. The patient, however, needs to be informed that the surgical option may still be necessary if bleeding gets heavier or is persistent beyond a reasonable time.

Primary options

misoprostol: 800 micrograms intravaginally as a single dose, repeat once on day 3 if expulsion incomplete

More
Back
Plus – 

analgesics plus counseling

Treatment recommended for ALL patients in selected patient group

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
Back
1st line – 

conservative management

A significant number of women prefer conservative management allowing early pregnancy tissue to be expelled spontaneously. It may be continued as long as the patient is willing and provided there are no signs of infection such as vaginal discharge, excessive bleeding, pyrexia, or abdominal pain.

Follow-up scans may be arranged at 2-weekly intervals, until a diagnosis of complete miscarriage is made.

Ultrasound is preferred for confirming early pregnancy loss. The American College of Obstetricians and Gynecologists recommends that surgical intervention is not required in asymptomatic women who have a thickened endometrial stripe after undergoing treatment for pregnancy loss.[95]

Back
Plus – 

analgesics plus counseling

Treatment recommended for ALL patients in selected patient group

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More

complete miscarriage

Back
1st line – 

analgesics plus counseling

Analgesics are imperative in the presence of pain and discomfort, and nonsteroidal anti-inflammatory drugs are best avoided. Acetaminophen is the analgesic of choice.

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief. Loss of an early pregnancy can affect couples as significantly as a neonatal death. The extremely low chance of repeat miscarriage should be mentioned if any worry is expressed about the future. Depending on hospital or healthcare facility policy, the removed early pregnancy tissue may be sent for histopathology, after obtaining parental consent and offering counseling.

Primary options

acetaminophen: 500-1000 mg every 4-6 hours when required, maximum 4000 mg/day

Back
Consider – 

Rho (D) immune globulin

Treatment recommended for SOME patients in selected patient group

In the US, the American College of Obstetricians and Gynecologists recommends that women who are rhesus negative and unsensitized should receive Rho (D) immune globulin within 72 hours of a potentially sensitizing event in the first or second trimester. However, whether to administer Rho (D) immune globulin to a patient with threatened pregnancy loss and a live embryo or fetus at or before 12 weeks of gestation is controversial, and no evidence-based recommendation can be made. Because of the higher risk of alloimmunization, rhesus-negative women who receive surgical management of their miscarriage should receive Rh D prophylaxis.[95][124]

Primary options

Rho(D) immune globulin: 300 micrograms intramuscularly/intravenously as a single dose

More

OR

Rho(D) immune globulin: 50 micrograms intramuscularly as a single dose

More
ONGOING

recurrent miscarriage

Back
1st line – 

treatment of underlying cause

Although 1 in 5 women with a history of recurrent miscarriage may have further pregnancy loss, the other proportion do well, even without any intervention.

The European Society for Human Reproduction and Gynaecology has provided recommendations for the treatment of recurrent miscarriage.[77]

No intervention is advised in women with unexplained miscarriage.[129]

Multivitamins and folic acid supplementation have no confirmed benefit and are not recommended as treatment; however, if patients ask about using supplements you should advise which ones are safe in pregnancy as some supplements are associated with possible harms. Cervical cerclage may benefit second-trimester recurrent miscarriages, possibly explained by cervical incompetence, insufficiency, or weakness.

Neither anticoagulants nor aspirin have been shown to help prevent early pregnancy loss in women with thrombophilias (excluding those with antiphospholipid syndrome).[95][77][Evidence C]

Patients with antiphospholipid syndrome or multiple inherited thrombophilias have been treated with low-dose aspirin that is started before conception. These patients may also require heparin therapy following a positive pregnancy test, until delivery. Addition of unfractionated heparin to aspirin is more effective at reducing pregnancy loss compared with the addition of low molecular weight heparin.

With regards to immunotherapy in the treatment of unexplained miscarriage, paternal cell immunization, third-party donor leukocytes, trophoblast membranes, and intravenous immunoglobulin provide no significant beneficial effect over placebo in improving the live birth rate.[123] [ Cochrane Clinical Answers logo ]

There is conflicting evidence regarding treatment with metformin in some women with polycystic ovarian disease in relation to reducing miscarriage rates.[77]

It should be remembered that clinical evaluation of potential treatments for recurrent miscarriage are best undertaken in the context of controlled clinical trials. If a physician offers empirical treatment, it should be made clear to the patient that this is a departure from optimum clinical practice.[3]

Back
Plus – 

counseling

Treatment recommended for ALL patients in selected patient group

Counseling for the mothers (or couples) should be given. A patient information pamphlet should also be provided. Prolonged psychological or psychiatric support may be needed in some patients. Some women experience guilt in addition to their grief.

Referral to a specialist unit is often appreciated, even if no successful pregnancy is eventually achieved.

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer